Hereditary peroxisomal diseases

被引:1
|
作者
Astudillo, Leonardo [1 ,2 ,3 ,6 ]
Sabourdy, Frederique [2 ,3 ,4 ,6 ]
Touati, Guy [5 ,6 ]
Levade, Thierry [2 ,3 ,4 ,6 ]
机构
[1] CHU Purpan, Serv Med Interne, Toulouse, France
[2] Inserm UMR1037, Toulouse, France
[3] Univ Toulouse, Ctr Rech Cancerol Toulouse, Toulouse, France
[4] CHU Purpan, Inst Federatif Biol, Lab Biochim Metab, Toulouse, France
[5] CHU Purpan, Serv Pediat, Toulouse, France
[6] Ctr Competence Malad Hereditaires Metab Sud Ouest, Toulouse, France
来源
PRESSE MEDICALE | 2016年 / 45卷 / 03期
关键词
HYPERPIPECOLIC ACIDEMIA; DEFICIENCY; PROTEIN; CLASSIFICATION; MITOCHONDRIAL; MUTATIONS; DIAGNOSIS; SPECTRUM; THERAPY; DEFECT;
D O I
10.1016/j.lpm.2015.05.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Peroxisomes are small intracellular organelles that catalyse key metabolic reactions such as the beta-oxidation of some straight-chain or branched-chain fatty acids and the alpha-oxidation of phytanic acid. These enzyme reactions produce hydrogen peroxide, which is subsequently neutralized by the peroxisomal catalase. Peroxisomes also metabolize glyoxylate to glycine, and catalyze the first steps of plasmalogen biosynthesis. There are more than a dozen inherited peroxisomal disorders in humans. These metabolic diseases are due to monogenic defects that affect either a single function (such as enzyme or a transporter) or more than two distinct functions because of the impairment of several aspects of peroxisome biogenesis. With the notable exception of X-linked adrenoleucodystrophy, these inborn disorders are transmitted as autosomal recessive traits. Their clinical presentation can be very heterogeneous, and include neonatal, infantile or adult forms. The present review describes the symptomatology of these genetic diseases, the underlying genetic and biochemical alterations, and summarizes their diagnostic approach.
引用
收藏
页码:302 / 312
页数:11
相关论文
共 50 条
  • [1] PEROXISOMAL DISEASES
    MOSER, HW
    [J]. ADVANCES IN HUMAN GENETICS, 1993, 21 : 1 - &
  • [2] PEROXISOMAL DISEASES
    PALOSAARI, PM
    KILPONEN, JM
    HILTUNEN, JK
    [J]. ANNALS OF MEDICINE, 1992, 24 (03) : 163 - 166
  • [3] PEROXISOMAL DISEASES
    AUBOURG, P
    [J]. PRESSE MEDICALE, 1987, 16 (08): : 391 - 396
  • [4] Peroxisomal diseases - Overview
    Theron, JJ
    vanPapendorp, DH
    [J]. SOUTH AFRICAN MEDICAL JOURNAL, 1996, 86 (06): : 685 - 690
  • [5] Neuropathology of peroxisomal diseases
    Martin, JJ
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 1995, 18 : 19 - 33
  • [6] Demyelination in peroxisomal diseases
    Powers, JA
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 228 (02) : 206 - 207
  • [7] PEROXISOMAL DISEASES, AN OVERVIEW
    GOLDFISCHER, SL
    [J]. EUROPEAN JOURNAL OF CELL BIOLOGY, 1986, 41 : 15 - 15
  • [8] Epilepsy in peroxisomal diseases
    Takahashi, Y
    Suzuki, Y
    Kumazaki, K
    Tanabe, Y
    Akaboshi, S
    Miura, K
    Shimozawa, N
    Kondo, N
    Nishiguchi, T
    Terada, K
    Orii, T
    [J]. EPILEPSIA, 1997, 38 (02) : 182 - 188
  • [9] Peroxisomes, Peroxisomal Diseases, and the Hepatotoxicity Induced by Peroxisomal Metabolites
    Wanders, Ronald J. A.
    Ferdinandusse, Sacha
    [J]. CURRENT DRUG METABOLISM, 2012, 13 (10) : 1401 - 1411
  • [10] CLINICAL PRESENTATION OF PEROXISOMAL DISEASES
    STOCKLER, S
    [J]. JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1989, 27 (05): : 301 - 301